These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia. Muramatsu H; Makishima H; Jankowska AM; Cazzolli H; O'Keefe C; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP Blood; 2010 Mar; 115(10):1969-75. PubMed ID: 20008299 [TBL] [Abstract][Full Text] [Related]
23. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011 [TBL] [Abstract][Full Text] [Related]
24. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now? De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370 [TBL] [Abstract][Full Text] [Related]
25. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Hecht A; Meyer JA; Behnert A; Wong E; Chehab F; Olshen A; Hechmer A; Aftandilian C; Bhat R; Choi SW; Chonat S; Farrar JE; Fluchel M; Frangoul H; Han JH; Kolb EA; Kuo DJ; MacMillan ML; Maese L; Maloney KW; Narendran A; Oshrine B; Schultz KR; Sulis ML; Van Mater D; Tasian SK; Hofmann WK; Loh ML; Stieglitz E Haematologica; 2022 Jan; 107(1):178-186. PubMed ID: 33375775 [TBL] [Abstract][Full Text] [Related]
26. A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing. Wang WH; Lu MY; Tsai CH; Wang SC; Chou SW; Jou ST J Formos Med Assoc; 2021 Apr; 120(4):1148-1152. PubMed ID: 32933826 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of juvenile myelomonocytic leukemia. Sakashita K; Matsuda K; Koike K Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988 [TBL] [Abstract][Full Text] [Related]
34. [Clinical features and prognosis of juvenile myelomonocytic leukemia: an analysis of 63 cases]. Yang WY; Liu LP; Liu F; Qi BQ; Chang LX; Zhang L; Chen XJ; Zou Y; Chen YM; Guo Y; Zhu XF Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):265-271. PubMed ID: 36946161 [TBL] [Abstract][Full Text] [Related]
35. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features. Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488 [TBL] [Abstract][Full Text] [Related]
36. Germline bi-allelic Arfeuille C; Vial Y; Cadenet M; Caye-Eude A; Fenneteau O; Neven Q; Bonnard AA; Pizzi S; Carpentieri G; Capri Y; Girardi K; Pedace L; Macchiaiolo M; Boudhar K; Khaled MB; Chahla WA; Lutun A; Fahd M; Drunat S; Flex E; Dalle JH; Strullu M; Locatelli F; Tartaglia M; Cavé H Haematologica; 2024 Aug; 109(8):2542-2554. PubMed ID: 37981895 [TBL] [Abstract][Full Text] [Related]
37. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia. Yoshimi A; Kamachi Y; Imai K; Watanabe N; Nakadate H; Kanazawa T; Ozono S; Kobayashi R; Yoshida M; Kobayashi C; Hama A; Muramatsu H; Sasahara Y; Jakob M; Morio T; Ehl S; Manabe A; Niemeyer C; Kojima S Pediatr Blood Cancer; 2013 May; 60(5):836-41. PubMed ID: 23023736 [TBL] [Abstract][Full Text] [Related]
38. How I treat juvenile myelomonocytic leukemia. Locatelli F; Niemeyer CM Blood; 2015 Feb; 125(7):1083-90. PubMed ID: 25564399 [TBL] [Abstract][Full Text] [Related]
39. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia. Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340 [TBL] [Abstract][Full Text] [Related]
40. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Sakashita K; Kato I; Daifu T; Saida S; Hiramatsu H; Nishinaka Y; Ebihara Y; Ma F; Matsuda K; Saito S; Hirabayashi K; Kurata T; Uyen LT; Nakazawa Y; Tsuji K; Heike T; Nakahata T; Koike K Leukemia; 2015 Mar; 29(3):606-14. PubMed ID: 25102944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]